ChinaBio Today -- China biopharma is very different from its western counterparts, and for foreigners, its high rate of change further complicates the difficulty of understanding the sector (see story). That was the common theme that ran through four presentations at this week’s ChinaBio® Executive Workshop, “Leveraging China to Build a Global Biotech.” Each of the four presenters used their expertise to shed light on one facet of the world of China biopharma.
